Zimmer Biomet Holdings Inc Asset Resilience Ratio
Zimmer Biomet Holdings Inc asset resilience ratio. Zimmer Biomet Holdings Inc (ZBH) has an Asset Resilience Ratio of 6.24% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Zimmer Biomet Holdings Inc (ZBH) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Zimmer Biomet Holdings Inc (2003–2024)
Asset resilience ratio of Zimmer Biomet Holdings Inc from 2003 to 2024. This chart shows how Zimmer Biomet Holdings Inc's Asset Resilience Ratio has changed over time. Read how much debt does Zimmer Biomet Holdings Inc carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Zimmer Biomet Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Zimmer Biomet Holdings Inc total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.38 Billion | 6.24% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $1.38 Billion | 6.24% |
Asset Resilience Insights
- Limited Liquidity: Zimmer Biomet Holdings Inc maintains only 6.24% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Zimmer Biomet Holdings Inc Industry Peers by Asset Resilience Ratio
Compare Zimmer Biomet Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
Zimmer Biomet Holdings Inc Asset Resilience Ratio by Year (2003–2024)
Zimmer Biomet Holdings Inc asset resilience ratio by year from 2003 to 2024. The table below shows the annual Asset Resilience Ratio data for Zimmer Biomet Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.46% | $525.50 Million | $21.37 Billion | +0.40pp |
| 2023-12-31 | 2.06% | $442.00 Million | $21.50 Billion | +0.24pp |
| 2022-12-31 | 1.82% | $382.50 Million | $21.07 Billion | -0.29pp |
| 2021-12-31 | 2.11% | $494.80 Million | $23.46 Billion | -1.18pp |
| 2020-12-31 | 3.28% | $802.10 Million | $24.42 Billion | +0.78pp |
| 2019-12-31 | 2.51% | $617.90 Million | $24.64 Billion | +0.26pp |
| 2018-12-31 | 2.25% | $542.80 Million | $24.13 Billion | +0.23pp |
| 2017-12-31 | 2.02% | $524.40 Million | $26.01 Billion | -0.36pp |
| 2016-12-31 | 2.38% | $634.10 Million | $26.68 Billion | +1.78pp |
| 2015-12-31 | 0.60% | $164.60 Million | $27.41 Billion | -5.76pp |
| 2014-12-31 | 6.36% | $612.50 Million | $9.63 Billion | -1.23pp |
| 2013-12-31 | 7.59% | $727.00 Million | $9.58 Billion | +0.14pp |
| 2012-12-31 | 7.45% | $671.60 Million | $9.01 Billion | +2.10pp |
| 2011-12-31 | 5.35% | $455.50 Million | $8.52 Billion | +2.04pp |
| 2010-12-31 | 3.31% | $265.10 Million | $8.00 Billion | +2.46pp |
| 2009-12-31 | 0.85% | $66.40 Million | $7.79 Billion | +0.82pp |
| 2008-12-31 | 0.04% | $2.70 Million | $7.24 Billion | 0.00pp |
| 2007-12-31 | 0.04% | $2.50 Million | $6.63 Billion | 0.00pp |
| 2006-12-31 | 0.04% | $2.40 Million | $5.97 Billion | -0.17pp |
| 2005-12-31 | 0.21% | $12.10 Million | $5.72 Billion | -0.12pp |
| 2004-12-31 | 0.33% | $18.90 Million | $5.70 Billion | +0.05pp |
| 2003-12-31 | 0.28% | $14.50 Million | $5.16 Billion | -- |
About Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skul… Read more